Everhart Financial Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Sell
1,939
-111
-5% -$62.3K 0.07% 166
2026
Q1
$1.15M Sell
2,050
-76
-4% -$48.7K 0.1% 143
2025
Q4
$1.44M Buy
2,126
+164
+8% +$112K 0.13% 101
2025
Q3
$1.25M Buy
1,962
+139
+8% +$84.4K 0.13% 108
2025
Q2
$978K Buy
1,823
+538
+42% +$257K 0.11% 121
2025
Q1
$540K Buy
1,285
+539
+72% +$234K 0.07% 191
2024
Q4
$308K Sell
746
-213
-22% -$93.4K 0.06% 253
2024
Q3
$485K Sell
959
-235
-20% -$114K 0.11% 196
2024
Q2
$582K Buy
1,194
+214
+22% +$107K 0.15% 138
2024
Q1
$529K Buy
980
+68
+7% +$37.2K 0.15% 140
2023
Q4
$506K Buy
912
+132
+17% +$62K 0.18% 112
2023
Q3
$341K Sell
780
-13
-2% -$6.48K 0.14% 139
2023
Q2
$398K Buy
793
+27
+4% +$12.9K 0.16% 120
2023
Q1
$383K Buy
766
+68
+10% +$32.5K 0.17% 111
2022
Q4
$285K Buy
+698
New +$271K 0.14% 127

Other funds holding IDXX

Everhart Financial Group's IDXX Position: Q2 2026 in Review

Everhart Financial Group reduced its Idexx Laboratories (IDXX) stake by 5.4% in Q2 2026, selling an estimated $62.3K and leaving 1,939 shares worth $1.02M. The position accounts for 0.07% of the portfolio, ranked #166.

Everhart Financial Group first reported a position in IDXX in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.44M in Q4 2025. 204 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Everhart Financial Group held 1,939 shares of Idexx Laboratories worth $1.02M as of Q2 2026.
  • Everhart Financial Group sold 111 Idexx Laboratories shares in Q2 2026, an estimated $62.3K.
  • Idexx Laboratories made up 0.07% of Everhart Financial Group's portfolio in Q2 2026, its #166 holding.
  • Everhart Financial Group first reported a position in Idexx Laboratories in Q4 2022 and has held it in 15 quarters since.
  • Everhart Financial Group's Idexx Laboratories position peaked at $1.44M in Q4 2025.
  • 204 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.